Biotech and Pharma stocks with 250%+ ROI opportunities

Sharing is Caring!

by Qryptoqurrency

$TRXC — Yesterday, I posted an update on $TRXC hoping to give people on the sidelines opportunities to invest their money into promising companies — $TRXC closed today +6.18%. This stock has been a Strong Buy since mid-2 dollars and has been one of the biggest winners already this year, but with the 3mm FDA approval coming up and the recent acquisition, I’m confident that this one will continue to run up through EOY. If they announce commercial sales, this stock will likely go parabolic.

$VSTM — received FDA Approval of COPIKTRA™ (duvelisib) Capsules, an oral medicine for cancer patients. Verastem Oncology™ has COM (composition-of-matter) patent protection of duvelisib through 2030 before extensions. This company has $165 MILLION in cash. They announced on their call today that they will be announcing another major partner by EOY. I expect the price target of this stock to be $15+ by end of year. This company is currently under $1B market cap.

See also  Stocks could be due for a correction of up to 20% ‘by fire or ice’: Morgan Stanley strategist

$TRVN — popped today for +13.37%. Technical analysis initially is the main reason why I thought there was a huge trade opportunity, but after reading about the company and pipeline, I may just hold the stocks long-term. A lot of analysts have $TRVN’s price target above $10. (finance.yahoo.com/news/analysts-bet-trevena-trvn-pain-003603980.html)

See also  Pimco High Income ETF Breakdown Would Be Bad For Stocks!

$GERN — Sad I didn’t pull the trigger on this one. Popped today for +13.55% during regular hours and +7.58% AH.

$CRMD — closed regular hours +3.75% and +5.38% AH.

What other biotech/pharma stocks are you all bullish on? Would love to hear your tickets and DD!

 

Disclaimer: Consult your financial professional before making any investment decision.

594 views

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.